Currents status and prospects of autologous bone marrow cell infusion therapy for liver cirrhosis patients
スポンサーリンク
概要
- 論文の詳細を見る
We developed a novel cell therapy (ABMi therapy) using autologous bone marrow cells for liver cirrhosis patients. Our study depends on the findings from basic studies using GFP/CCl4 models. Beginning in November 2003, we started clinical trials of ABMi therapy and found it to be safe and effective for liver cirrhosis patients. Multicenter trials in Japan and Korea have also shown the effectiveness of ABMi therapy. In this review, we discuss translational research for the development of ABMi therapy for liver cirrhosis patients.
- Yamaguchi University School of Medicineの論文
Yamaguchi University School of Medicine | 論文
- Regression of abdominal aortic aneurysms by pharmacological inhibition of c-Jun N-terminal kinase
- Role of alpha-actinin-4 in the regulation of endocytosis
- Immunoglobulin G1 allotypes in intravenous immunoglobulin non-responders of kawasaki disease patients
- The free radical scavenger edaravone protects hair cells against aminoglycoside toxicity
- Associations between markers of inflammation and cholinergic blockade and delirium in intensive care unit patients: A pilot study